This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tang, W. H. W. Articles by Young, J. B. Search for Related Content PubMed PubMed Citation Articles by Tang, W. H. W. Articles by Young, J. B.

Fluid retention after initiation of thiazolidinedione therapy in diabetic patients with established chronic heart failure

W. H. Wilson Tang, MD^*,*, Gary S. Francis, MD, FACC^*, Byron J. Hoogwerf, MD and James B. Young, MD, FACC^*

^* Department of Cardiovascular Medicine, Cleveland, Ohio, USA
Department of Endocrinology, Cleveland Clinic Foundation, Cleveland, Ohio, USA

View larger version (47K): [in a new window]   Figure 1 Study design. HF = heart failure; TZD = thiazolidinedione.

View larger version (19K): [in a new window]   Figure 2 A comparison of clinical manifestations of fluid retention between thiazolidinedione (TZD) users and non-TZD users.